Skip to content
you are here

Routine Testing

Monitoring patient safety in clinical trials...

Being able to help in the field of clinical studies, help patients, help the Sponsors that develop new drugs, and help then improving health conditions. That's what it means to me working at Barc Lab.

Pieter Bogaert
CSO Barc Lab

Routine safety testing at Barc Lab: all you need to know…

At Barc Lab, we recognize that next to all the specialty testing, routine safety analyses still remain the backbone of your clinical trials. Barc Lab has a broad portfolio of routine testing, including but not limited to traditional hematology, biochemistry, serology and urinalysis. Thanks to our business model, where our clinical trials activity is integrated into large medical laboratories, we can provide global analyses of all your routine samples. We offer a fully automated approach for these assays including a high throughput and excess capacity across all our locations.

We are committed to secure standardization on a global scale by correlating all instruments through regular external proficiency tests and guarantee the same reference ranges can be used. Harmonizing our Standard Operations Procedures (SOPs) and using uniform methods and instruments in all our global laboratories enables us to ensure you that all generated results are comparable and can be combined through one global database.

Key instruments:

  • Sysmex
  • Roche Cobas®
  • Beckman Coulter
  • DiaSorin Liaison®
  • Siemens Advia Centaur
  • Abbott Architect

 

Laboratory testing plays a foremost role in clinical trials, wherein routine analyses are used to accurately monitor safety of your innovative therapy. Contact us to find out how Barc Lab offers an integrated combination of routine and specialty testing sustained by state-of-the-art technologies.

circles
Pieter Bogaert, PhD

Pieter Bogaert, PhD, CSO

Pieter holds a PhD in Sciences and started to work at the Cerba HealthCare group as Head of the Flow Cytometry department in 2014. In 2018, Pieter started to act as Barc Lab’s Chief Scientific Officer.